Man’s asthma inhaler cost went from $66 to $539, then he died, Wisconsin lawsuit says
The family of a Wisconsin man is suing after they say he died from an asthma attack when his medication price rose from $66 ...
Hosted on MSN14d
UnitedHealth's OptumRx Accused of Excessive Drug Pricing
The Federal Trade Commission accused UnitedHealth's OptumRx, CVS Caremark, and Cigna's Express Scripts of pocketing over $7 billion in markups on generic specialty drugs over a 5-year period. The Big ...
Wisconsin family files federal lawsuit against pharmacy chain and PBM over son’s death
The cost of Cole Schmidtknecht’s asthma inhaler was raised to over $500. His parents said Cole chose rent over medicine. Days ...
The FTC Finds United Health’s OptumRX Is Engaged In Widespread Price Gouging
The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from ...
'Chose rent over his medicine': Parents of 22-year-old who died from asthma attack sue pharmacy over inhaler price jump
The parents of a young Wisconsin man have sued Walgreens and pharmacy benefit manager OptumRx over their son’s death from an ...
Boston Globe: 'Knock out the middlemen' is a campaign promise Donald Trump should keep
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
Money Morning1d
3 Pharma Stocks Getting Fat Off GLP-1: Here's the Best Buy Now
Cardinal Health had $210 billion in pharmaceutical and specialty drugs sales in fiscal 2024, up 11% year-over-year, helped in large part by GLP-1 sales. In Q4, segment sales rose 13% to $55 billion, ...
Insider Monkey on MSN1d
Why UnitedHealth Group Incorporated (UNH) is the Best Stock to Buy in 2025 for Beginners
UnitedHealth Group Incorporated (NYSE:UNH) employed around $17 billion in growth capital in fiscal 2024 to strengthen its ...
The Hill16d
PBMs made billions marking up specialty drugs by more than 1,000 percent: FTC
The report specifically looked at the business practices of the Caremark Rx, Express Scripts and OptumRx, which are in turn owned by CVS Health, Cigna and UnitedHealth Group, respectively.
Campus Safety Magazine15d
FTC: ‘Big 3’ Pharmacy Benefit Managers Engaged in Price Gouging
On Tuesday, the U.S. Federal Trade Commission (FTC) presented evidence that UnitedHealth Group’s OptumRx, along with its two main competitors, Express Scripts and CVS Caremark Rx, inflated the ...
Yahoo News17d
Top three insurers reaped $7.3 billion through their drug middlemen's markups, FTC says
The top pharmacy benefit managers (PBMs) — CVS Health’s Caremark Rx, Cigna’s Express Scripts and UnitedHealth Group’s OptumRx — generated roughly $7.3 billion through price hikes over about five years ...